EU Parliament and Council provisionally approve Critical Medicines Act to strengthen drug supply chains

The European Parliament and the Council have provisionally voted to adopt the Critical Medicines Act, marking a key step toward its implementation.

The legislation is designed to reinforce the EU’s supply chains for medicines deemed essential, aiming to reduce shortages and improve resilience.

By establishing new requirements for manufacturers and distributors, the act seeks to ensure a more reliable flow of critical drugs across member states.

The provisional approval signals political support, though the final text will still need to be formally adopted before becoming law.